Holotranscobalamin Levels in Children with Helicobacter pylori Infection

Oguz Afyoncu1, Orhan Gursel2, Avni Atay2

  • 1Department of Pediatrics, Gulhane Military Medical Academy and Medical Faculty, Ankara, Turkey.

Helicobacter
|May 19, 2015
PubMed

Insights

Helicobacter pylori infection in children lowers vitamin B12 status, specifically holotranscobalamin (holoTC) levels. This effect is reversible and normalizes after H. pylori treatment.

Area of Science:

  • Pediatric Gastroenterology
  • Nutritional Biochemistry

Background:

  • Helicobacter pylori (H. pylori) infection is common in children.
  • Vitamin B12 deficiency can lead to various health issues.
  • Holotranscobalamin (holoTC) is an active form of vitamin B12.

Purpose of the Study:

  • To investigate the association between H. pylori infection and vitamin B12 levels in children.
  • To assess the diagnostic utility of holoTC in children with H. pylori infection.

Main Methods:

  • Study included 30 children (6-15 years) with H. pylori infection and 26 controls.
  • Evaluated complete blood count, serum vitamin B12, folate, homocysteine, and plasma holoTC.
  • H. pylori infection diagnosed via C(14) urea breath test.

Main Results:

  • Children with H. pylori infection had significantly lower plasma holoTC levels before treatment.
  • Plasma holoTC levels normalized after H. pylori eradication therapy.
  • No significant changes were observed in total plasma vitamin B12 levels.

Conclusions:

  • H. pylori infection negatively impacts vitamin B12 status in children, indicated by reduced holoTC.
  • The effect on holoTC is reversible and resolves with successful H. pylori treatment.
  • HoloTC measurement may be a sensitive indicator of vitamin B12 status in pediatric H. pylori infection.
Abstract

Related Concept Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
2.3K
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
840
Serum Laboratory Studies, Stool Test, Breath Test01:30

Serum Laboratory Studies, Stool Test, Breath Test

Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
1.2K
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the...
33
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
353